Radiation zaps severe depression in bold new trial
NCT ID NCT07274917
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 2 times
Summary
This study tests whether a precise type of radiation, called stereotactic radiotherapy, can safely reduce symptoms in people with treatment-resistant depression. Nine adults aged 18 to 50 who have not improved after at least two antidepressant trials will receive the treatment. Researchers will measure changes in depression severity using a standard questionnaire over several weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Anding Hospital, Capital Medical University
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mind-Body physio program aims to tackle chronic pain and depression together
- Brain 'Radio' tunes into Depression's neural signals
- Can a customized talk therapy lift depression in autistic teens?
- Brain scans may reveal if magnetic therapy hits the right spot for depression
- Smartwatch data may forecast bipolar mood swings
- Magic mushroom compound tested for dual relief of chronic pain and depression